These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17105224)

  • 1. Biologically active amphotericin B-calix[4]arene conjugates.
    Paquet V; Zumbuehl A; Carreira EM
    Bioconjug Chem; 2006; 17(6):1460-3. PubMed ID: 17105224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.
    Paquet V; Volmer AA; Carreira EM
    Chemistry; 2008; 14(8):2465-81. PubMed ID: 18196508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and investigation of tryptophan-amphotericin B conjugates.
    Zumbuehl A; Stano P; Sohrmann M; Dietiker R; Peter M; Carreira EM
    Chembiochem; 2009 Jul; 10(10):1617-20. PubMed ID: 19533712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.
    Paquet V; Carreira EM
    Org Lett; 2006 Apr; 8(9):1807-9. PubMed ID: 16623556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel strategy for bioconjugation: synthesis and preliminary evaluation with amphotericin B.
    Zumbuehl A; Stano P; Sohrmann M; Peter M; Walde P; Carreira EM
    Org Biomol Chem; 2007 May; 5(9):1339-42. PubMed ID: 17464400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive fluorinated derivative of amphotericin B.
    Matsumori N; Umegawa Y; Oishi T; Murata M
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3565-7. PubMed ID: 15963721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of amphotericin B derivatives.
    Volmer AA; Szpilman AM; Carreira EM
    Nat Prod Rep; 2010 Sep; 27(9):1329-49. PubMed ID: 20556271
    [No Abstract]   [Full Text] [Related]  

  • 8. Antifungal activity of amphotericin B conjugated to carbon nanotubes.
    Benincasa M; Pacor S; Wu W; Prato M; Bianco A; Gennaro R
    ACS Nano; 2011 Jan; 5(1):199-208. PubMed ID: 21141979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-covered drug particles: combined action of dioctadecyldimethylammonium bromide and amphotericin B or miconazole.
    Lincopan N; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2006 Jul; 58(1):66-75. PubMed ID: 16636081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Band intensity in the IR spectra and conformations of calix[4]arene and thiacalix[4]arene.
    Furer VL; Borisoglebskaya EI; Kovalenko VI
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(1-2):355-9. PubMed ID: 15556460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly identified derivative of amphotericin B: isolation, structure determination and primary evaluation of the activity and toxicity.
    Wang YH; Zhang JP; Chang Y; Hu CQ
    J Antibiot (Tokyo); 2010 Sep; 63(9):553-7. PubMed ID: 20606697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.
    Palacios DS; Anderson TM; Burke MD
    J Am Chem Soc; 2007 Nov; 129(45):13804-5. PubMed ID: 17956100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-conductance cholesterol-amphotericin B channels in reconstituted lipid bilayers.
    Yilma S; Cannon-Sykora J; Samoylov A; Lo T; Liu N; Brinker CJ; Neely WC; Vodyanoy V
    Biosens Bioelectron; 2007 Feb; 22(7):1359-67. PubMed ID: 16842986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of purity and potency of amphotericin B by HPLC.
    Chang Y; Wang YH; Hu CQ
    J Antibiot (Tokyo); 2011 Nov; 64(11):735-9. PubMed ID: 21971300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calix[4]arene-cholic acid conjugates: a new class of efficient synthetic ionophores.
    Maulucci N; De Riccardis F; Botta CB; Casapullo A; Cressina E; Fregonese M; Tecilla P; Izzo I
    Chem Commun (Camb); 2005 Mar; (10):1354-6. PubMed ID: 15742076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the role of the mycosamine C2'-OH on the activity of amphotericin B.
    Croatt MP; Carreira EM
    Org Lett; 2011 Mar; 13(6):1390-3. PubMed ID: 21322610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical "knockout" challenges the amphotericin B channel model.
    Kozmin SA
    Nat Chem Biol; 2008 Jan; 4(1):19-20. PubMed ID: 18084276
    [No Abstract]   [Full Text] [Related]  

  • 18. Optically pure calix[6]tris-ammoniums: syntheses and host-guest properties toward neutral guests.
    Darbost U; Zeng X; Giorgi M; Jabin I
    J Org Chem; 2005 Dec; 70(25):10552-60. PubMed ID: 16323870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of chromate and phosphate anion from aqueous solutions using calix[4]aren receptors containing proton switchable units.
    Ertul S; Bayrakci M; Yilmaz M
    J Hazard Mater; 2010 Sep; 181(1-3):1059-65. PubMed ID: 20579808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.